MedPage Today Features Perspective from Dr. Henry Parkman on Findings Presented at ACG on Tegoprazan, Potential Medication for Non-Erosive Reflux Disease

Perspective from Henry P. Parkman, MD, Stanley H. Lorber Research Endowment Fund and Chair of Gastroenterology at the Lewis Katz School of Medicine at Temple University, was featured in a MedPage Today article on results from a phase III trial on tegoprazan, a novel, fast-acting, oral potassium-competitive acid blocker, presented at the American College of Gastroenterology annual meeting. The findings showed patients with non-erosive reflux disease who took once-daily tegoprazan had a significant reduction in heartburn frequency.